Dr. Andrew H Lipsky
Claim this profileColumbia University Medical Center
Studies Mantle Cell Lymphoma
Studies Lymphoma
3 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Andrew H Lipsky is currently running
Polatuzumab Vedotin + Chemotherapy
for Richter Syndrome
This trial tests a combination of drugs to treat patients with a severe type of lymphoma. The treatment aims to kill cancer cells and boost the immune system. Patients will be monitored closely for an extended period to see how well they respond.
Recruiting1 award Phase 210 criteria
GFH009
for Blood Cancer
SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single agent SLS009 are assessed in two dose escalation groups (Group 1 in patients with relapsed/refractory AML, Group 2 in patients with relapse/refractory lymphoma/CLL/SLL). The safety, tolerability, and antitumor activity of SLS009 in combination with venetoclax and azacitidine in patient with relapsed/refractory AML who have relapsed on or are refractory to venetoclax-based regimens are being assessed in five cohorts of the expansion Group 3.
Recruiting1 award Phase 1 & 27 criteria
More about Andrew H Lipsky
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andrew H Lipsky has experience with
- LOXO-305
- Polatuzumab Vedotin
- Hydroxydaunomycin
- Cyclophosphamide
- Rituximab
- Etoposide
Breakdown of trials Andrew H Lipsky has run
Mantle Cell Lymphoma
Chronic B-Cell Leukemia
Richter Syndrome
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew H Lipsky specialize in?
Andrew H Lipsky focuses on Mantle Cell Lymphoma and Lymphoma. In particular, much of their work with Mantle Cell Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Andrew H Lipsky currently recruiting for clinical trials?
Yes, Andrew H Lipsky is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Andrew H Lipsky has studied deeply?
Yes, Andrew H Lipsky has studied treatments such as LOXO-305, Polatuzumab Vedotin, Hydroxydaunomycin.
What is the best way to schedule an appointment with Andrew H Lipsky?
Apply for one of the trials that Andrew H Lipsky is conducting.
What is the office address of Andrew H Lipsky?
The office of Andrew H Lipsky is located at: Columbia University Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.